Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087612301> ?p ?o ?g. }
- W3087612301 endingPage "108504" @default.
- W3087612301 startingPage "108504" @default.
- W3087612301 abstract "The potential anti-cancer properties of selenium (Se) and eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) have been documented. However, few studies have been conducted examining anti-tumor effects of nutritional supplements (NS) containing Se and EPA/DHA in combination with anti-cancer agents, such as taxol (Tax), adriamycin (Adr), and avastin (Ava). Compared with triple-negative breast cancer (TNBC)-bearing positive control (TB) mice, a low dose of Tax, Adr, and Ava decreased tumor size and the incidence of metastasis in TB-Tax, TB-Adr, and TB-Ava groups. Combination treatment with anti-cancer agent and NS (2.7 μg Se and 5.1 mg EPA/3.7 mg DHA/g) induced additional decreases in TB-Tax-NS, TB-Adr-NS, and TB-Ava-NS groups. Th1-associated cytokines were increased, and Th2-type cytokines were decreased significantly in TB mice with combination treatment than that of anti-cancer agent treatment alone. Combination treatment with anti-cancer agents and NS has also been shown to further increased tumor malondialdehyde (MDA) levels, lowered hypoxia-inducible factor (HIF)-1α, angiogenic markers (vascular endothelial growth factor [VEGF] and CD31) and metastatic potential, as well as reduced heat shock proteins, receptor tyrosine kinase AXL, and surface markers of cancer stem cells, and increased apoptotic proteins. For immune checkpoint molecules, combination treatment was associated with a greater decrease in programmed cell death ligand-1 (PD-L1) in both tumors and mammary glands, but PD-1 level in primary tumors was increased. Our results suggest that combination treatment with low-dose anti-cancer agents (Tax, Adr, and Ava) and oral supplementation of Se/ EPA/DHA significantly decreased tumor growth and metastatic progression in TNBC mice through multiple anti-tumor mechanisms." @default.
- W3087612301 created "2020-09-25" @default.
- W3087612301 creator A5009904657 @default.
- W3087612301 creator A5033416669 @default.
- W3087612301 creator A5043555656 @default.
- W3087612301 creator A5045731651 @default.
- W3087612301 creator A5047378720 @default.
- W3087612301 creator A5056803518 @default.
- W3087612301 creator A5065165004 @default.
- W3087612301 creator A5066218543 @default.
- W3087612301 creator A5066252639 @default.
- W3087612301 creator A5076038503 @default.
- W3087612301 date "2021-01-01" @default.
- W3087612301 modified "2023-10-01" @default.
- W3087612301 title "Nutritional supplements in combination with chemotherapy or targeted therapy reduces tumor progression in mice bearing triple-negative breast cancer" @default.
- W3087612301 cites W1514409003 @default.
- W3087612301 cites W1517771226 @default.
- W3087612301 cites W1585788967 @default.
- W3087612301 cites W1789924039 @default.
- W3087612301 cites W1874198014 @default.
- W3087612301 cites W1968351069 @default.
- W3087612301 cites W1978573204 @default.
- W3087612301 cites W1993971268 @default.
- W3087612301 cites W1998629360 @default.
- W3087612301 cites W2010297851 @default.
- W3087612301 cites W2011046820 @default.
- W3087612301 cites W2020857952 @default.
- W3087612301 cites W2024504871 @default.
- W3087612301 cites W2024542453 @default.
- W3087612301 cites W2029237663 @default.
- W3087612301 cites W2036159218 @default.
- W3087612301 cites W2065443310 @default.
- W3087612301 cites W2085460331 @default.
- W3087612301 cites W2099166599 @default.
- W3087612301 cites W2107554353 @default.
- W3087612301 cites W2113545156 @default.
- W3087612301 cites W2126275851 @default.
- W3087612301 cites W2132286757 @default.
- W3087612301 cites W2132491086 @default.
- W3087612301 cites W2149542744 @default.
- W3087612301 cites W2165936545 @default.
- W3087612301 cites W2170466734 @default.
- W3087612301 cites W2170602872 @default.
- W3087612301 cites W2220466462 @default.
- W3087612301 cites W2279779120 @default.
- W3087612301 cites W2290466312 @default.
- W3087612301 cites W2344746583 @default.
- W3087612301 cites W2408391265 @default.
- W3087612301 cites W2495185657 @default.
- W3087612301 cites W2502845086 @default.
- W3087612301 cites W2552965505 @default.
- W3087612301 cites W2560684070 @default.
- W3087612301 cites W2586117957 @default.
- W3087612301 cites W2589193607 @default.
- W3087612301 cites W2592127988 @default.
- W3087612301 cites W2610858500 @default.
- W3087612301 cites W2622400061 @default.
- W3087612301 cites W2626249377 @default.
- W3087612301 cites W2745124429 @default.
- W3087612301 cites W2750978572 @default.
- W3087612301 cites W2752822966 @default.
- W3087612301 cites W2753738234 @default.
- W3087612301 cites W2753815799 @default.
- W3087612301 cites W2765632487 @default.
- W3087612301 cites W2791709331 @default.
- W3087612301 cites W2793852801 @default.
- W3087612301 cites W2803280445 @default.
- W3087612301 cites W2895674659 @default.
- W3087612301 cites W2900847421 @default.
- W3087612301 cites W2944653505 @default.
- W3087612301 cites W2986572941 @default.
- W3087612301 cites W3006668915 @default.
- W3087612301 doi "https://doi.org/10.1016/j.jnutbio.2020.108504" @default.
- W3087612301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32956826" @default.
- W3087612301 hasPublicationYear "2021" @default.
- W3087612301 type Work @default.
- W3087612301 sameAs 3087612301 @default.
- W3087612301 citedByCount "12" @default.
- W3087612301 countsByYear W30876123012020 @default.
- W3087612301 countsByYear W30876123012021 @default.
- W3087612301 countsByYear W30876123012022 @default.
- W3087612301 countsByYear W30876123012023 @default.
- W3087612301 crossrefType "journal-article" @default.
- W3087612301 hasAuthorship W3087612301A5009904657 @default.
- W3087612301 hasAuthorship W3087612301A5033416669 @default.
- W3087612301 hasAuthorship W3087612301A5043555656 @default.
- W3087612301 hasAuthorship W3087612301A5045731651 @default.
- W3087612301 hasAuthorship W3087612301A5047378720 @default.
- W3087612301 hasAuthorship W3087612301A5056803518 @default.
- W3087612301 hasAuthorship W3087612301A5065165004 @default.
- W3087612301 hasAuthorship W3087612301A5066218543 @default.
- W3087612301 hasAuthorship W3087612301A5066252639 @default.
- W3087612301 hasAuthorship W3087612301A5076038503 @default.
- W3087612301 hasConcept C121608353 @default.
- W3087612301 hasConcept C126322002 @default.
- W3087612301 hasConcept C134018914 @default.
- W3087612301 hasConcept C185592680 @default.
- W3087612301 hasConcept C19038510 @default.